DBV Technologies (DBVT) Enterprise Value (QoQ) (2020 - 2026)
DBV Technologies (DBVT) Enterprise Value (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.69% |
| Mar 31, 2026 | -18.02% |
| Dec 31, 2025 | -178.08% |
| Sep 30, 2025 | 32.33% |
| Jun 30, 2025 | -696.23% |
| Mar 31, 2025 | 60.06% |
| Dec 31, 2024 | 30.11% |
| Sep 30, 2024 | 29.86% |
| Jun 30, 2024 | 34.78% |
| Mar 31, 2024 | 28.18% |
| Dec 31, 2023 | 5.21% |
| Sep 30, 2023 | 14.27% |
| Jun 30, 2023 | 9.53% |
| Mar 31, 2023 | 8.08% |
| Dec 31, 2022 | 1.63% |
| Sep 30, 2022 | 14.24% |
| Jun 30, 2022 | -234.61% |
| Mar 31, 2022 | 4.13% |
| Dec 31, 2021 | 21.28% |
| Sep 30, 2021 | 21.75% |